Tau phosphorylation in Alzheimer's disease: pathogen or protector?
about
Oxidative Stress Signaling in Alzheimers DiseaseNovel therapeutics for Alzheimer's disease: an updateMild cognitive impairment: pathology and mechanisms.Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's diseaseAmyloid-beta Alzheimer targets - protein processing, lipid rafts, and amyloid-beta poresTau and tauopathiesThe physiological link between metabolic rate depression and tau phosphorylation in mammalian hibernationBiochemical assessment of precuneus and posterior cingulate gyrus in the context of brain aging and Alzheimer's diseaseSome evolutionary perspectives on Alzheimer's disease pathogenesis and pathologyImaging phenotypes of major depressive disorder: genetic correlatesIncreased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment.Biomarkers in Alzheimer's disease: past, present and future.Mitochondrial Drugs for Alzheimer Disease.Antioxidant therapy in Alzheimer's disease: theory and practice.A synergistic dysfunction of mitochondrial fission/fusion dynamics and mitophagy in Alzheimer's disease.Inflammasomes in neuroinflammation and changes in brain function: a focused review.Involvement of oxidative stress in Alzheimer disease.Gender-Specific Expression of Ubiquitin-Specific Peptidase 9 Modulates Tau Expression and Phosphorylation: Possible Implications for Tauopathies.Neurofibrillary and neurodegenerative pathology in APP-transgenic mice injected with AAV2-mutant TAU: neuroprotective effects of Cerebrolysin.Oligomer formation of tau protein hyperphosphorylated in cells.Immunolesion-induced loss of cholinergic projection neurones promotes β-amyloidosis and tau hyperphosphorylation in the hippocampus of triple-transgenic mice.Suppression of autophagy and activation of glycogen synthase kinase 3beta facilitate the aggregate formation of tau.A network of RNA and protein interactions in Fronto Temporal Dementia.Hyperphosphorylation of intrinsically disordered tau protein induces an amyloidogenic shift in its conformational ensemble.Phosphorylation of tau antagonizes apoptosis by stabilizing beta-catenin, a mechanism involved in Alzheimer's neurodegeneration.Insulin resistance in the nervous systemTau phosphorylation and aggregation in Alzheimer's disease pathology.Neurogenesis and cell cycle-reactivated neuronal death during pathogenic tau aggregationAntioxidant protection and neurodegenerative disease: the role of amyloid-beta and tau.Cholesterol, statins and tau.Current strategies for the treatment of Alzheimer's disease and other tauopathies.Tau phosphorylation, aggregation, and cell toxicityThe triggering receptor expressed on myeloid cells 2: "TREM-ming" the inflammatory component associated with Alzheimer's diseaseTau imaging in neurodegenerative diseases.The modulation of metal bio-availability as a therapeutic strategy for the treatment of Alzheimer's disease.Sustained high levels of neuroprotective, high molecular weight, phosphorylated tau in the longest-lived rodentCharacteristics of tau oligomers.The effect of mGluR2 activation on signal transduction pathways and neuronal cell survival.Phosphorylated tau: toxic, protective, or none of the aboveCell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's disease.
P2860
Q22241327-78BA6535-3191-447F-91B6-F603877CC842Q24620383-611F6B88-CC0E-4B9A-B591-39862816C0B6Q24631255-98EDCF8A-6287-443F-891D-6D1A2FE27321Q24656640-FC8E6159-E782-4DDE-908C-C54A21650FD6Q26738355-52F9D00B-E3EE-4CD0-AC00-49E8150513E9Q27027415-10C6B7F3-0911-478F-AF33-2FA87C3A2B39Q27314753-9B50066B-890C-4FA6-9C48-C24E79B299DBQ28542628-68EF2E0E-5EC0-425D-9FBE-9424E8230C26Q28705398-4E92DA90-A3A3-4B86-807F-BE238A3899EDQ30478592-7056C14E-AD7B-4E53-8CD4-22DF7BCCF50DQ33740552-4CA175DC-81C8-4AE5-8BD9-392FF6AF1D2AQ33791646-BBEBB19C-B27B-4287-A0C4-42EE0CFABC3BQ34016406-7F94FE28-96B4-4999-948A-BA98C743ECFCQ34066474-75D69E32-2C70-4338-AF77-AF11AA347ECFQ34073879-45C1B3C4-9B0D-4325-8A08-FB75906DEE6EQ34299338-21BF06F6-16FD-4C85-9799-D7276EA9C2F4Q34545547-714DDFFA-F5D4-4D9B-8444-24D8181306A7Q34545616-1854EE4F-7C7A-4AC7-BC2A-DED7E687CAB9Q34629320-4C6AEB96-0DA4-4EF4-946A-AD70F97D4989Q34634346-008F1BD7-F0F7-4FAE-9118-EEC3ABAE43D9Q34659234-D89696DA-C9D2-4627-A659-F4176A144456Q35014018-2AE85503-EC02-410D-B773-E07E4885B01DQ35194634-877802DC-6455-46AE-B7DE-C3F045461259Q35576517-A7AF6560-B8E5-40F2-A99D-7C1255974328Q35652167-B59BAC34-716B-4599-96D4-B9CF4E6E91FEQ36084516-827175CC-855A-434E-A01C-2E639AB56CA8Q36418199-6684A017-9227-4666-AAD7-54F79DFA3914Q36454890-26F887CA-1F66-4CCC-ADD4-157DFF34CA72Q36458314-20208892-7059-4643-B1C4-CC21CAAC3101Q36546527-39CEB64D-E635-4BA1-8328-1E55AA5585A7Q36596669-87C67A7E-9213-4951-9EB4-3924A958CD56Q36626384-0699F986-70C2-439A-86AD-25958D0B3504Q36711780-6A34488B-8789-4879-A71C-F3565D67FDBEQ36834567-1CF99F1F-0A35-4359-B4FE-ED92D43407BAQ36872887-C1A1345E-B39B-4CF3-BAED-CAB2B754EE1BQ36907724-06688AE9-6DEB-4096-AEE6-FE17F2AF0E40Q37025521-5E22DF22-A83F-4659-A67E-D966F5BB823CQ37232609-8CBEF697-ECB7-444C-A91C-39D93B4A53A6Q37238262-52850E66-AA6B-46B8-8681-BA74B7F60EB6Q37359655-0DD42E40-ACAF-4AC6-A57B-BFA37F6AF912
P2860
Tau phosphorylation in Alzheimer's disease: pathogen or protector?
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Tau phosphorylation in Alzheimer's disease: pathogen or protector?
@ast
Tau phosphorylation in Alzheimer's disease: pathogen or protector?
@en
Tau phosphorylation in Alzheimer's disease: pathogen or protector?
@nl
type
label
Tau phosphorylation in Alzheimer's disease: pathogen or protector?
@ast
Tau phosphorylation in Alzheimer's disease: pathogen or protector?
@en
Tau phosphorylation in Alzheimer's disease: pathogen or protector?
@nl
prefLabel
Tau phosphorylation in Alzheimer's disease: pathogen or protector?
@ast
Tau phosphorylation in Alzheimer's disease: pathogen or protector?
@en
Tau phosphorylation in Alzheimer's disease: pathogen or protector?
@nl
P2093
P50
P1476
Tau phosphorylation in Alzheimer's disease: pathogen or protector?
@en
P2093
Akihiko Nunomura
Atsushi Takeda
Hyoung-Gon Lee
Matthew R Garrett
P356
10.1016/J.MOLMED.2005.02.008
P407
P577
2005-04-01T00:00:00Z